title: Intratumoral injection of OK-432 suppresses metastatic squamous cell carcinoma lesion inducing interferon-γ and tumour necrosis factor-α.
authors: T
authors: T
authors: Akeda
authors: K
authors: K
authors: Yamanaka
authors: H
authors: H
authors: Kitagawa
authors: E
authors: E
authors: Kawabata
authors: K
authors: K
authors: Tsuda
authors: M
authors: M
authors: Kakeda
authors: Y
authors: Y
authors: Omoto
authors: K
authors: K
authors: Habe
authors: K
authors: K
authors: Isoda
authors: I
authors: I
authors: Kurokawa
authors: H
authors: H
authors: Mizutani
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000276:immunology / Q000556:secondary; D006801:Humans; D015552:Injections, Intralesional; D007371:Interferon-gamma / Q000378:metabolism*; D008297:Male; D010844:Picibanil / Q000008:administration & dosage*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000276:immunology; D047368:Tumor Burden / Q000187:drug effects; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D014409:Tumor Necrosis Factor-alpha; D010844:Picibanil; D007371:Interferon-gamma